Loading publications…
The last 5 uploaded publications
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
Jordi Bruix, Jean‐Luc Raoul, Morris Sherman, Vincenzo Mazzaferro, Luigi Bolondi, Antonio Craxı̀, Peter R. Galle, Armando Santoro, Michel Beaugrand, Angelo Sangiovanni, Camillo Porta, Guido Gerken, Jorge A. Marrero, Andrea Nadel, Michael Shan, M. Moscovici, D. Voliotis, Josep M. Llovet (2012). Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial. Journal of Hepatology, 57(4), pp. 821-829, DOI: 10.1016/j.jhep.2012.06.014.
Article146 days agoAASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma
Amit G. Singal, Josep M. Llovet, Mark Yarchoan, Neil Mehta, Julie K. Heimbach, Laura A. Dawson, Janice H. Jou, Laura Kulik, Vatche G. Agopian, Jorge A. Marrero, Mishal Mendiratta‐Lala, Daniel B. Brown, William S. Rilling, Lipika Goyal, Alice C. Wei, Tamar H. Taddei (2023). AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma. Hepatology, 78(6), pp. 1922-1965, DOI: 10.1097/hep.0000000000000466.
Article146 days agoα-Fetoprotein, Des-γ Carboxyprothrombin, and Lectin-Bound α-Fetoprotein in Early Hepatocellular Carcinoma
Jorge A. Marrero, Ziding Feng, Yinghui Wang, Mindie H. Nguyen, Alex S. Befeler, Lewis R. Roberts, K. Rajender Reddy, Denise M. Harnois, Josep M. Llovet, Daniel P. Normolle, Jackie Dalhgren, David Chia, Anna S. Lok, Paul D. Wagner, Sudhir Srivastava, Myron Schwartz (2009). α-Fetoprotein, Des-γ Carboxyprothrombin, and Lectin-Bound α-Fetoprotein in Early Hepatocellular Carcinoma. Gastroenterology, 137(1), pp. 110-118, DOI: 10.1053/j.gastro.2009.04.005.
Article146 days agoTrial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus Conference
Josep M. Llovet, Augusto Villanueva, Jorge A. Marrero, Myron Schwartz, Tim Meyer, Peter R. Galle, Riccardo Lencioni, Tim F. Greten, Masatoshi Kudo, Sumithra J. Mandrekar, Andrew X. Zhu, Richard S. Finn, Lewis R. Roberts (2020). Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus Conference. Hepatology, 73(S1), pp. 158-191, DOI: 10.1002/hep.31327.
Article146 days agoInternational Liver Cancer Association (ILCA) White Paper on Biomarker Development for Hepatocellular Carcinoma
Amit G. Singal, Yujin Hoshida, David J. Pinato, Jorge A. Marrero, Jean‐Charles Nault, Valérie Paradis, Nabihah Tayob, Morris Sherman, Young‐Suk Lim, Ziding Feng, Anna S. Lok, Jo Ann Rinaudo, Sudhir Srivastava, Josep M. Llovet, Augusto Villanueva (2021). International Liver Cancer Association (ILCA) White Paper on Biomarker Development for Hepatocellular Carcinoma. Gastroenterology, 160(7), pp. 2572-2584, DOI: 10.1053/j.gastro.2021.01.233.
Article146 days ago